HOPKINSON CRAIG C. (EVP R&D, Chief Medical Officer) sold 9.1% of their position (9K shares) of ALKERMES PLC. on the open market
Open‑market sale worth $267.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Ordinary Shares
Shares
+5K
Price / share
$19.34
Trade value
$96.70K
% of position
Ordinary Shares
Shares
−9K
Price / share
$29.72
Trade value
$267.49K
% of position
Net shares
−4K
Net value
-$170.79K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 3/2/2026 | M · Option Exercise | +5K | $19.34 | $96.70K | 5.4% | 93.39K | 98.39K |
| Ordinary Shares Direct | 3/2/2026 | S · Sale | −9K | $29.72 | $267.49K | 9.1% | 98.39K | 89.39K |
| Total | −4K | -$170.79K | ||||||
Employee Stock Option (Right to Buy)
Ordinary Shares
5K shares
Shares
−5K
Strike price
19.34
Held after
21.36K
Exercisable
—
Employee Stock Option (Right to Buy)
Ordinary Shares
83.04K shares
Shares
+83.04K
Strike price
30.25
Held after
83.04K
Exercisable
—
Restricted Stock Unit Award
Ordinary Shares
38.57K shares
Shares
+38.57K
Strike price
Held after
38.57K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Ordinary Shares5K shares | 3/2/2026 | M · Option Exercise | −5K | 19.34 | — | 21.36K |
| Employee Stock Option (Right to Buy) Direct | Ordinary Shares83.04K shares | 3/2/2026 | A · Award | +83.04K | 30.25 | — | 83.04K |
| Restricted Stock Unit Award Direct | Ordinary Shares38.57K shares | 3/2/2026 | A · Award | +38.57K | — | 38.57K |